Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201208111 Principal Investigator: Picus, Joel
Title: A Study of HSP90 Inhibitor AT13387 Alone or in Combination with Abiraterone Acetate in the Treatment of Castration-Resistant Prostate Cancer (CRPC) no Longer Responding to Abiraterone
Phase: I/II Disease Site: Prostate
Participating Site(s):
 
Main Campus
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to look at the safety and tolerability of AT13387 when given alone or in combination with abiraterone acetate and steroids, and to find out the best treatment plan for AT13387 alone and in combination with abiraterone acetate and steroids when given to patients with prostate cancer who are no longer responding to treatment with abiraterone acetate and steroids alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)